Year |
Citation |
Score |
2015 |
Palekar RU, Jallouk AP, Goette MJ, Chen J, Myerson JW, Allen JS, Akk A, Yang L, Tu Y, Miller MJ, Pham CT, Wickline SA, Pan H. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 3100-9. PMID 25857553 DOI: 10.1096/Fj.14-269084 |
0.552 |
|
2015 |
Chen J, Vemuri C, Palekar RU, Gaut JP, Goette M, Hu L, Cui G, Zhang H, Wickline SA. Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology. 308: F765-73. PMID 25651565 DOI: 10.1152/Ajprenal.00457.2014 |
0.579 |
|
2015 |
Goette MJ, Lanza GM, Caruthers SD, Wickline SA. Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation. Journal of Magnetic Resonance Imaging : Jmri. 42: 488-94. PMID 25425244 DOI: 10.1002/Jmri.24812 |
0.581 |
|
2015 |
Goette MJ, Keupp J, Rahmer J, Lanza GM, Wickline SA, Caruthers SD. Balanced UTE-SSFP for 19F MR imaging of complex spectra. Magnetic Resonance in Medicine. 74: 537-43. PMID 25163853 DOI: 10.1002/Mrm.25437 |
0.5 |
|
2013 |
Goette MJ, Schmieder AH, Williams TA, Allen JS, Keupp J, Lanza GM, Wickline SA, Caruthers SD. Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B1-mapping compensation for 19F-MRI Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-O83 |
0.613 |
|
2012 |
Goette MJ, Schmieder AH, Williams TA, Allen JS, Keupp J, Lanza G, Wickline SA, Caruthers SD. In Vivo quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using 19F-MRI with ultra-short echo time balanced SSFP Journal of Cardiovascular Magnetic Resonance. 14. DOI: 10.1186/1532-429X-14-S1-M8 |
0.587 |
|
2011 |
Marsh JN, Hu G, Scott MJ, Zhang H, Goette MJ, Gaffney PJ, Caruthers SD, Wickline SA, Abendschein D, Lanza GM. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine (London, England). 6: 605-15. PMID 21506686 DOI: 10.2217/Nnm.11.21 |
0.55 |
|
Show low-probability matches. |